03871nam 22005415 450 991030043990332120221121232947.0981-10-7596-410.1007/978-981-10-7596-4(CKB)4100000001795049(DE-He213)978-981-10-7596-4(MiAaPQ)EBC5255554(PPN)223954306(EXLCZ)99410000000179504920180130d2018 u| 0engurnn#008mamaatxtrdacontentcrdamediacrrdacarrierEarly-stage Lung Cancer Screening and Management /edited by Xiangpeng Zheng, Ming Li, Guozhen Zhang1st ed. 2018.Singapore :Springer Singapore :Imprint: Springer,2018.1 online resource (XXIV, 423 p. 181 illus. in color.)981-10-7595-6 Includes bibliographical references at the end of each chapters and index.The pathological advances of early lung adenocarcinoma -- Advancement in Cross-sectional Anatomy of the Lung -- Low-dose CT Screening of Lung Cancer -- The Advances of PET/CT clinical application in micronodular lung cancer -- Angiogenesis-dependent tumor progression -- Pure Ground-glass Nodules -- Part-solid Ground-glass Nodules -- Solid Pulmonary Nodules -- CT-based Categorization of Small Pulmonary Adenocarcinoma and Differential Diagnosis -- Multiple Primary Lung Cancer -- Management Strategies of Micronodular Lung Cancer: Surgical Perspectives -- Management Strategies of Early-stageLung Cancer: Stereotactic Ablative Radiation Therapy -- Radiofrequency ablation -- Case Discussion.This book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for CT imaging. Part II focuses on the imaging features, differential diagnosis and radiologic-pathologic correlations of ESLCs in the categories pGGN, mGGN and solid nodules in compliance with the Guidelines on Lung Cancer Screening from the National Comprehensive Cancer Network (NCCN). Part III briefly introduces therapeutic management strategies for ESLCs, including surgical and non-surgical approaches, for instance stereotactic ablative radiation therapy (SABR) and radiofrequency ablation (RFA). Lastly, the authors have meticulously prepared 50 clinical cases of pathologically proven benign and malignant pulmonary nodules with in-depth discussion and experts’ comments to further readers’ understanding of practical imaging and management strategies of ESLCs.Respiratory organs—DiseasesRadiologyOncologyPneumology/Respiratory Systemhttps://scigraph.springernature.com/ontologies/product-market-codes/H33134Diagnostic Radiologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H29013Oncologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H33160Respiratory organs—Diseases.Radiology.Oncology.Pneumology/Respiratory System.Diagnostic Radiology.Oncology.616.2Zheng Xiangpengedthttp://id.loc.gov/vocabulary/relators/edtLi Ming(Of Shanghai Hua dong yi yuan),edthttp://id.loc.gov/vocabulary/relators/edtZhang Guozhenedthttp://id.loc.gov/vocabulary/relators/edtBOOK9910300439903321Early-stage Lung Cancer1744487UNINA